The importance of the differentiating syndromes for the efficacy assessment of Chinese medicine in the treatment of cancer.
Wu
Wan-yin
WY
Department of Cancer, Second Clinical School of Guangzhou University of Traditional Chinese Medicine, Guangzhou 510370, China. wwangyin@126.com
D014408:Biomarkers, Tumor / Q000032:analysis; D003937:Diagnosis, Differential; D018450:Disease Progression; D005069:Evaluation Studies as Topic; D006801:Humans; D008516:Medicine, Chinese Traditional / Q000009:adverse effects / Q000379:methods*; D009367:Neoplasm Staging / Q000379:methods; D009369:Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D013577:Syndrome; D016896:Treatment Outcome
D014408:Biomarkers, Tumor